Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Root Extracts Limited has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and is located in 1 distinct art unit. This represents a highly focused prosecution profile with a single active matter.
SAIDHA, TEKCHAND is the busiest examiner for this portfolio, holding the pending office action. The involvement of a distinct examiner and art unit for the pending action indicates a singular point of contact for all current prosecution.
In the Biotechnology & Pharmaceuticals technology area, this pending office action is managed entirely by SAIDHA, TEKCHAND. There are no other examiners or art units involved in the pending workload. This concentration means that the prosecution strategy is entirely dependent on the interaction with this examiner in the 1 art unit. This focused environment allows for a direct and consistent communication channel during the prosecution process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAIDHA, TEKCHAND | 1 | 82.9% | +14.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18878242 | POTATO PROTEIN EXTRACTION APPARATUS AND METHOD | SAIDHA, TEKCHAND | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18878242 | POTATO PROTEIN EXTRACTION APPARATUS AND METHOD | SAIDHA, TEKCHAND | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18878242 | POTATO PROTEIN EXTRACTION APPARATUS AND METHOD | SAIDHA, TEKCHAND | 1652 | §112 | Non-Final OA | — | Pending | Dec 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRoot Extracts Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Tekchand Saidha has the most, with 1 of Root Extracts Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
